434 related articles for article (PubMed ID: 36323829)
1. Ferroptosis inhibitor liproxstatin-1 alleviates metabolic dysfunction-associated fatty liver disease in mice: potential involvement of PANoptosis.
Tong J; Lan XT; Zhang Z; Liu Y; Sun DY; Wang XJ; Ou-Yang SX; Zhuang CL; Shen FM; Wang P; Li DJ
Acta Pharmacol Sin; 2023 May; 44(5):1014-1028. PubMed ID: 36323829
[TBL] [Abstract][Full Text] [Related]
2. Non-Necroptotic Roles of MLKL in Diet-Induced Obesity, Liver Pathology, and Insulin Sensitivity: Insights from a High-Fat, High-Fructose, High-Cholesterol Diet Mouse Model.
Ohene-Marfo P; Nguyen HVM; Mohammed S; Thadathil N; Tran A; Nicklas EH; Wang D; Selvarani R; Farriester JW; Varshney R; Kinter M; Richardson A; Rudolph MC; Deepa SS
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474061
[TBL] [Abstract][Full Text] [Related]
3. Si-Wu-Tang alleviates metabolic dysfunction-associated fatty liver disease by inhibiting ACSL4-mediated arachidonic acid metabolism and ferroptosis in MCD diet-fed mice.
Xue X; Wang L; Wu R; Li Y; Liu R; Ma Z; Jia K; Zhang Y; Li X
Chin Med; 2024 Jun; 19(1):79. PubMed ID: 38844978
[TBL] [Abstract][Full Text] [Related]
4. Puerarin ameliorates metabolic dysfunction-associated fatty liver disease by inhibiting ferroptosis and inflammation.
Yang M; Xia L; Song J; Hu H; Zang N; Yang J; Zou Y; Wang L; Zheng X; He Q; Liu J; Liu F; Liang K; Sun L; Chen L
Lipids Health Dis; 2023 Nov; 22(1):202. PubMed ID: 38001459
[TBL] [Abstract][Full Text] [Related]
5. Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis.
Tsurusaki S; Tsuchiya Y; Koumura T; Nakasone M; Sakamoto T; Matsuoka M; Imai H; Yuet-Yin Kok C; Okochi H; Nakano H; Miyajima A; Tanaka M
Cell Death Dis; 2019 Jun; 10(6):449. PubMed ID: 31209199
[TBL] [Abstract][Full Text] [Related]
6. [Tanshinone Ⅱ_A inhibits ferroptosis via Nrf2 signaling pathway to protect liver in rats of non-alcoholic fatty liver disease].
Qin Z; Zhou M
Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(6):1611-1620. PubMed ID: 38621946
[TBL] [Abstract][Full Text] [Related]
7. Ferroptosis Affects the Progression of Nonalcoholic Steatohepatitis via the Modulation of Lipid Peroxidation-Mediated Cell Death in Mice.
Qi J; Kim JW; Zhou Z; Lim CW; Kim B
Am J Pathol; 2020 Jan; 190(1):68-81. PubMed ID: 31610178
[TBL] [Abstract][Full Text] [Related]
8. Ferroptosis and metabolic dysfunction-associated fatty liver disease: Is there a link?
Feng G; Byrne CD; Targher G; Wang F; Zheng MH
Liver Int; 2022 Jul; 42(7):1496-1502. PubMed ID: 35007392
[TBL] [Abstract][Full Text] [Related]
9. [Intestinal flora polymorphisms with different lesional stages in an animal model of MAFLD].
Xia QY; Lu D; Zhang JM; Wei YC; Yang MM; Yang ZY; Cao MB
Zhonghua Gan Zang Bing Za Zhi; 2021 Nov; 29(11):1069-1076. PubMed ID: 34933425
[No Abstract] [Full Text] [Related]
10. Si-Ni-San Reduces Hepatic Lipid Deposition in Rats with Metabolic Associated Fatty Liver Disease by AMPK/SIRT1 Pathway.
Zhang N; Liu T; Wang J; Xiao Y; Zhang Y; Dai J; Ma Z; Ma D
Drug Des Devel Ther; 2023; 17():3047-3060. PubMed ID: 37808345
[TBL] [Abstract][Full Text] [Related]
11. Assessment of mitochondrial function in metabolic dysfunction-associated fatty liver disease using obese mouse models.
Zhao QY; Ge LH; Zhang K; Chen HF; Zhan XX; Yang Y; Dang QL; Zheng Y; Zhou HB; Lyu JX; Fang HZ
Zool Res; 2020 Sep; 41(5):539-551. PubMed ID: 32786176
[TBL] [Abstract][Full Text] [Related]
12. The gut microbiota metabolite glycochenodeoxycholate activates TFR-ACSL4-mediated ferroptosis to promote the development of environmental toxin-linked MAFLD.
Liu S; Gao Z; He W; Wu Y; Liu J; Zhang S; Yan L; Mao S; Shi X; Fan W; Song S
Free Radic Biol Med; 2022 Nov; 193(Pt 1):213-226. PubMed ID: 36265794
[TBL] [Abstract][Full Text] [Related]
13. HA-20 prevents hepatocyte steatosis in metabolic-associated fatty liver disease via regulating Ca
Wang J; Du MM; Du Y; Li JX
Eur J Pharmacol; 2022 Apr; 921():174838. PubMed ID: 35218717
[TBL] [Abstract][Full Text] [Related]
14. Taohe Chengqi decoction alleviated metabolic-associated fatty liver disease by boosting branched chain amino acids catabolism in the skeletal muscles of type 2 diabetes mellitus.
Yuan Z; Qiao H; Wang Z; Wang H; Han M; Zhang W; Zhou Y; Hassan HM; Zhao W; Qin T
Phytomedicine; 2024 Apr; 126():155315. PubMed ID: 38387274
[TBL] [Abstract][Full Text] [Related]
15. Targeting a novel inducible GPX4 alternative isoform to alleviate ferroptosis and treat metabolic-associated fatty liver disease.
Tong J; Li D; Meng H; Sun D; Lan X; Ni M; Ma J; Zeng F; Sun S; Fu J; Li G; Ji Q; Zhang G; Shen Q; Wang Y; Zhu J; Zhao Y; Wang X; Liu Y; Ouyang S; Sheng C; Shen F; Wang P
Acta Pharm Sin B; 2022 Sep; 12(9):3650-3666. PubMed ID: 36176906
[TBL] [Abstract][Full Text] [Related]
16. Study on the attenuated effect of Ginkgolide B on ferroptosis in high fat diet induced nonalcoholic fatty liver disease.
Yang Y; Chen J; Gao Q; Shan X; Wang J; Lv Z
Toxicology; 2020 Dec; 445():152599. PubMed ID: 32976958
[TBL] [Abstract][Full Text] [Related]
17. Metabolic-associated fatty liver disease and lipoprotein metabolism.
Heeren J; Scheja L
Mol Metab; 2021 Aug; 50():101238. PubMed ID: 33892169
[TBL] [Abstract][Full Text] [Related]
18. Jiuzhuan Huangjing Pills relieve mitochondrial dysfunction and attenuate high-fat diet-induced metabolic dysfunction-associated fatty liver disease.
Mu JK; Zi L; Li YQ; Yu LP; Cui ZG; Shi TT; Zhang F; Gu W; Hao JJ; Yu J; Yang XX
Biomed Pharmacother; 2021 Oct; 142():112092. PubMed ID: 34449316
[TBL] [Abstract][Full Text] [Related]
19. Heme oxygenase 1 alleviates nonalcoholic steatohepatitis by suppressing hepatic ferroptosis.
Yuan X; Li L; Zhang Y; Ai R; Li D; Dou Y; Hou M; Zhao D; Zhao S; Nan Y
Lipids Health Dis; 2023 Jul; 22(1):99. PubMed ID: 37422643
[TBL] [Abstract][Full Text] [Related]
20. 6-Gingerol regulates triglyceride and cholesterol biosynthesis to improve hepatic steatosis in MAFLD by activating the AMPK-SREBPs signaling pathway.
Xia Q; Lu F; Chen Y; Li J; Huang Z; Fang K; Hu M; Guo Y; Dong H; Xu L; Gong J
Biomed Pharmacother; 2024 Jan; 170():116060. PubMed ID: 38147735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
